According to a 2024 article by the Columbia University Department of Psychiatry, semaglutides 2021 FDA approval came with wide recognition for its medical benefits and its notable side effect of weight loss. What resulted from that was a surge in its off-label use as a weight-loss aid, propelling the drug into the spotlight far beyond its original intent. Then, also in 2021, the FDA approved Wegovy for individuals who are obese or overweight with additional health challenges. Columbia University also notes the ethical concerns of drugs like Ozempic and Wegovy, particularly in their pricing
Most patients tolerate Semaglutide injections well and only experience mild side effects
Taken consistently, this kind of gut support can help bring appetite, digestion, and overall metabolic well-being back into better alignmentrather than relying solely on medication
Off-label prescribing is extremely common, perfectly legal, and often represents the cutting edge of medicine
[24] Qiao L, Lu C, Zang T, Dzyuba B, Shao J